BIOCERES CROP SOLUTIONS CORP. Research and Development Expense
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Research and Development Expense of $2.35 million for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-13
- BIOCERES CROP SOLUTIONS CORP. research and development expense for the quarter ending 2025-12-31 was $2.35M, a 19.25% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. research and development expense for the quarter ending 2025-09-30 was $5.72M, a 29.59% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. research and development expense for the quarter ending 2025-06-30 was $2.65M, a 50.62% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. research and development expense for the quarter ending 2025-03-31 was $3.66M, a 1.94% increase year-over-year.
| Period end | Research And Development Expense 3 month | Research And Development Expense 3 month as first filed | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 9 month | Research And Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.35M 6-K · filed 2026-03-13 | $6.00M 6-K · filed 2026-03-13 | $10.71M derived: sum of 3 quarters · filed 2026-03-13 | $14.37M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2025-09-30 | $5.72M 6-K · filed 2025-11-26 | $8.37M derived: sum of 2 quarters · filed 2025-11-26 | $12.03M derived: sum of 3 quarters · filed 2025-11-26 | $14.00M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2025-06-30 | $2.65M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $6.31M derived: sum of 2 quarters · filed 2025-11-10 | $8.28M derived: sum of 3 quarters · filed 2026-03-13 | $14.91M 20-F · filed 2025-11-10 | ||
| 2025-03-31 | $3.66M 6-K · filed 2025-06-20 | $5.63M derived: sum of 2 quarters · filed 2026-03-13 | $12.26M 6-K · filed 2025-06-20 | $15.41M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2024-12-31 | $1.97M 6-K · filed 2026-03-13 | $4.19M 6-K · filed 2025-02-28 | $4.36M 6-K · filed 2026-03-13 | $8.60M 6-K · filed 2025-02-28 | $11.75M derived: sum of 3 quarters · filed 2026-03-13 | $15.34M derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-09-30 | $4.41M 6-K · filed 2025-11-26 | $9.78M derived: sum of 2 quarters · filed 2025-11-26 | $13.37M derived: sum of 3 quarters · filed 2025-11-26 | $17.01M derived: sum of 4 quarters · filed 2025-11-26 | ||
| 2024-06-30 | $5.37M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $8.96M derived: sum of 2 quarters · filed 2025-11-10 | $12.60M derived: sum of 3 quarters · filed 2025-11-10 | $17.18M 20-F · filed 2025-11-10 | ||
| 2024-03-31 | $3.59M 6-K · filed 2025-06-20 | $7.23M derived: sum of 2 quarters · filed 2025-06-20 | $11.81M 6-K · filed 2025-06-20 | $15.96M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-12-31 | $3.64M 6-K · filed 2025-02-28 | $8.22M 6-K · filed 2025-02-28 | $12.37M derived: sum of 3 quarters · filed 2025-11-10 | $16.26M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-09-30 | $4.58M 6-K · filed 2024-11-27 | $8.72M derived: sum of 2 quarters · filed 2025-11-10 | $12.62M derived: sum of 3 quarters · filed 2025-11-10 | $16.07M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2023-06-30 | $4.14M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $8.04M derived: sum of 2 quarters · filed 2025-11-10 | $11.49M derived: sum of 3 quarters · filed 2025-11-10 | $15.35M 20-F · filed 2025-11-10 | ||
| 2023-03-31 | $3.89M 6-K · filed 2024-05-29 | $7.35M derived: sum of 2 quarters · filed 2024-05-29 | $11.20M 6-K · filed 2024-05-29 | $13.50M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-12-31 | $3.46M 6-K · filed 2024-02-28 | $7.31M 6-K · filed 2024-02-28 | $9.61M derived: sum of 3 quarters · filed 2024-10-30 | $11.44M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-09-30 | $3.85M 6-K · filed 2023-11-29 | $6.15M derived: sum of 2 quarters · filed 2024-10-30 | $7.98M derived: sum of 3 quarters · filed 2024-10-30 | $9.37M derived: sum of 4 quarters · filed 2024-10-30 | ||
| 2022-06-30 | $2.30M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $4.13M derived: sum of 2 quarters · filed 2024-10-30 | $5.52M derived: sum of 3 quarters · filed 2024-10-30 | $6.95M 20-F · filed 2024-10-30 | ||
| 2022-03-31 | $1.84M 6-K · filed 2023-05-24 | $3.22M derived: sum of 2 quarters · filed 2023-05-24 | $4.65M 6-K · filed 2023-05-24 | |||
| 2021-12-31 | $1.38M 6-K · filed 2023-02-28 | $2.82M 6-K · filed 2023-02-28 | ||||
| 2021-06-30 | $5.62M 20-F · filed 2023-11-14 | |||||
| 2020-12-31 | $1.11M 6-K · filed 2022-02-25 | $2.14M 6-K · filed 2022-02-25 | ||||
| 2020-06-30 | $4.20M 20-F · filed 2022-10-28 | |||||
| 2019-12-31 | $923.61K 6-K · filed 2021-02-26 | $2.13M 6-K · filed 2021-02-26 | ||||
| 2019-06-30 | $3.69M 20-F · filed 2021-10-29 | |||||
| 2018-12-31 | $45.66K 6-K/A · filed 2020-03-17 | $1.09M 6-K/A · filed 2020-03-17 | ||||
| 2018-06-30 | $3.95M 20-F · filed 2020-10-21 | |||||
| 2017-06-30 | $1.99M 20-F · filed 2019-10-24 | |||||
| 2016-12-31 | $853.85K 20-F · filed 2019-10-24 |